Silexion Therapeutics Corp of RAMAT GAN, L3, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-11. The offering totals $3.6M, of which $3.6M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Dror Abramov | Director | Ramat Gan, L3 |
| Ruth Alon | Director | Ramat Gan, L3 |
| Ilan Hadar | Director | Ramat Gan, L3 |
| Ilan Levin | Director | Ramat Gan, L3 |
| Avner Lushi | Director | Ramat Gan, L3 |
| Shlomo Noy | Director | Ramat Gan, L3 |
| Amnon Peled | Director | Ramat Gan, L3 |
| Ilan Hadar | Executive Officer | Ramat Gan, L3 |
| Mirit Horenshtein-Hadar | Executive Officer | Ramat Gan, L3 |
| Mitchell Shirvan | Executive Officer | Ramat Gan, L3 |